- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04543084
Home Program Practice for People With Language Disorders After Stroke
August 31, 2023 updated by: Duquesne University
Improving Home Program Practice for People With Language Disorders After Stroke
Logbooks are one of the most commonly used methods to both support and track adherence in research studies.
This study will look at using logbooks to support adherence to reading practice for individuals with post-stroke aphasia.
It is thought that using a logbook will increase practice time.
Study Overview
Study Type
Interventional
Enrollment (Actual)
7
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15228
- Duquesne University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- at least 6 months post left hemisphere stroke with a diagnosis of aphasia
- must have self-reported interest in working to improve reading comprehension
- access to the Internet
- speak English as a primary language
Exclusion Criteria:
- significant visual or hearing impairment as determined by "aphasia-friendly" and age-appropriate screening
- actively receiving speech-language pathology services in which computerized or reading comprehension home practice activities are assigned/requested
- severe auditory comprehension impairment that limits understanding of one-step directions (i.e., Western Aphasia Battery-Revised sequential commands subtest score below 8).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Single-Subject Design
Each participant will go through a baseline phase and then an intervention phase.
|
Participants will record practice in a logbook.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in minutes of practice
Time Frame: Up to 11 weeks
|
The number of minutes practiced
|
Up to 11 weeks
|
Change in percentage of adherence to practice goal
Time Frame: Up to 11 weeks
|
The amount of practice compared to the goal
|
Up to 11 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reading comprehension
Time Frame: At first session and at last session time in between up to 5 months
|
As measured by performance on the Reading Comprehension Battery for Aphasia-2 (RCBA-2).
A higher score is better.
|
At first session and at last session time in between up to 5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elena V. Donoso Brown, PhD, Duquesne University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 22, 2021
Primary Completion (Actual)
September 6, 2022
Study Completion (Actual)
September 6, 2022
Study Registration Dates
First Submitted
August 27, 2020
First Submitted That Met QC Criteria
September 8, 2020
First Posted (Actual)
September 9, 2020
Study Record Updates
Last Update Posted (Actual)
September 1, 2023
Last Update Submitted That Met QC Criteria
August 31, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/12/11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
Clinical Trials on Logbook
-
Medical University of ViennaMedical University of Graz; Charite University, Berlin, Germany; Hannover Medical... and other collaboratorsCompletedSarcoma | Hematologic Diseases | Leukemia | Brain Tumor | Neurofibromatoses | NeuroblastomaAustria, Germany, Switzerland, Italy
-
University Hospital, AngersCompletedCardiovascular Diseases | Hypertension | Diabetes Mellitus, Type 2 | Sedentary Lifestyle | HypercholesterolemiaFrance
-
Centre Hospitalier Universitaire, AmiensWithdrawnAllogeneic Disease | Hematopoietic Stem Cell
-
Duke-NUS Graduate Medical SchoolSingHealth PolyclinicsUnknown
-
Centre Hospitalier Universitaire de NīmesRecruiting